Vulnerability record · CVE-2023-33364 · published 3 August 2023
CVE-2023-33364: Supremainc biostar 2 os command injection vulnerability
Supremainc · Biostar 2
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
Description
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Affected products
1 vulnerable configurations from NVD's CPE data, grouped by vendor and product.
References
| Link | Tags |
|---|---|
| https://claroty.com/team82/disclosure-dashboard/cve-2023-33364 | Third Party Advisory |
| https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291 | Release NotesVendor Advisory |
| https://claroty.com/team82/disclosure-dashboard/cve-2023-33364 | Third Party Advisory |
| https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291 | Release NotesVendor Advisory |
Track CVE-2023-33364 inside VULONE
Watch it alongside the ransomware crews, C2 infrastructure and forum chatter that reference it, query it through the API and pull it into your SIEM over TAXII.
Related vulnerabilities
Same products first, then exploited flaws of the same weakness class.
Source: NIST National Vulnerability Database (record CVE-2023-33364), CISA KEV, FIRST EPSS (scores of 2026-09-28). This page is refreshed as NVD updates the record.